Developmental aspects of anandamide: Ontogeny of response and prenatal exposure

Psychoneuroendocrinology

Volumn 21, Issue 2, 1996, Pages 157-172

  Fride, Ester ^a   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anandamide; Behaviour; Cannabinoids; Immunology; Ontogeny; Prenatal

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID; CANNABINOID RECEPTOR; LIPOPOLYSACCHARIDE;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CANNABIS ADDICTION; CATALEPSY; CONTROLLED STUDY; FETOTOXICITY; FETUS; GESTATIONAL AGE; IMMUNOREACTIVITY; LOCOMOTION; MOUSE; NONHUMAN; ONTOGENY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

EID: 0029890308     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4530(95)00039-9     Document Type: Article

References (80)

1. Abbey H, Howard E (1973) Statistical procedure in developmental studies on species and multiple offspring. Dev Psychobiol 6:329-335.
2. Abrahamov A, Abrahamov A, Mechoulam R (1995) An efficient new cannabinoid antiemetic in pedriatic oncology. Life Sci 56:2097-2102.
3. Ankier SI (1974) New hot plate tests to quantify antinocoception and narcotic antagonist activities. Eur J Pharmacol 27:1-4.
4. Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, et al. (1995) Cannabimimetic behavioral effects and adenylate cyclase inhibition by two new endogenous anandamides. Eur J Pharmacol 287:145-152.
5. Belue RC, Howlett AC, Westlake TM, Hutchings DE (1994) The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol 17:25-30.
6. Blackard C, Tennes K (1984) Human placental transfer of cannabinoids [letter]. N Engl J Med 311:797.
7. Bloch E, Fishman RH, Morrill GA, Fujimoto GI (1986) The effect of intragastric administration of delta 9-tetrahydrocannabinol on the growth and development of fetal mice of the A/J strain. Toxicol Appl Pharmacol 82:378-382.
8. Briggs GG, Freeman RK, Yaffe SJ (1990) Drugs in Pregnancy and Lactation, 3rd edn. Williams and Wilkins, Baltimore, pp 519-530.
9. Burstein SH, Audette CA, Doyle SA, Hull K, Hunter SA, Latham V (1989) Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid. J Pharmacol Exp Ther 251:531-535.
10. Chesher GB, Dahl CJ, Everingham M, Jackson DM, Marchant-Williams H, Starmer GA (1973) The effect of cannabinoids on intestinal motility and their antinococeptive effect in mice. Br J Pharmacol 49:588-594.
11. Crestani F, Seguy F, Dantzer R (1991) Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res 542:330-335.
12. Dahlof L-G, Hard E, Larsson K (1978) Influence of maternal stress on the development of the fetal genital system. Physiol Behav 20:193-195.
13. Dalterio SL (1986) Cannabinoid exposure: effects on development. Neurobehav Toxicol Teratol 8:345-352.
14. Dalterio S, Bartke A (1981) Fetal testosterone in mice: effect of gestational age and cannabinoid exposure. J Endocrinol 91:509-514.
15. Dalterio SL, Thomford PJ, Michael SD, DeAngelo L, Mayfield D (1986) Perinatal cannabinoid exposure: Effects on hepatic cytochrome P-450 and plasma protein levels in male mice. Teratol 33:195-201.
16. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
17. Devane WA, Hanuš L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
18. Diaz S, Specter S, Vanderhoek JY, Coffey RG (1994) The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells. J Pharmacol Exp Ther 268:1289-1296.
19. Di Marzio V, Fontana A, Cadas H, Schinelli GC, Schwartz J-C, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Science 372:686-690.
20. Dow-Edwards DL (1989) Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann NY Acad Sci 562:280-289.
21. Dreher MC, Nugent K, Hudgins R (1994) Prenatal marijuana exposure and neonatal outcomes in Jamaica - an ethnographic study. Pediatrics 93:254-260.
22. Eddy NB, Fuhrmeister Touchberry C, Lieberman JE (1953) Synthetic analgesics. I. Methadon isomers and derivatives. J Pharmacol 98:121-137.
23. Feigenbaum JJ, Richmond SA, Weissman Y, Mechoulam R (1989) Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid. Eur J Pharmacol 169:159-165.
24. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA (1992) Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol Pharmacol 42:838-845.
25. Fernandez-Ruiz JJ, Rodriguez de Fonseca F, Navarro M, Ramos JA (1992) Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopaminergic neurons. In: Bartke A, Murphy LL (Eds) Neurobiology and Neurophysiology of Cannabinoids, Biochemistry and Physiology of Substance Abuse, Vol. IV. CRC Press, Boca Raton.
26. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 272:699-707.
27. Fride E, Dan Y, Feldon J, Halevy G, Weinstock M (1986) Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats. Physiol Behav 37:681-687.
28. Fride E, Dan Y, Gavish M, Weinstock M (1985) Prenatal stress impairs maternal behavior in a conflict situation and reduces hippocampal benzodiazepine receptors. Life Sci 36:2103-2109.
29. Fride E, Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313-314.
30. Fride E, Weinstock M (1984) The effects of prenatal exposure to predictable or unpredictable stress on early development in the rat. Dev Psychobiol 17:651-660.
31. Fride E, Weinstock M (1988) Prenatal stress increases anxiety related behavior and alters cerebral lateralization of dopamine activity. Life Sci 42:1059-1065.
32. Fride E, Weinstock M (1989) Alterations in behavioral and striatal dopamine asymmetries induced by prenatal stress. Pharmacol Biochem Behav 32:425-430.
33. Fried PA (1976) Short and long-term effects of pre-natal cannabis inhalation upon rat offspring. Psychopharmacol Berl 50:285-291.
34. Fried PA (1994) The Ottawa prenatal prospective study (OPPS): Methodological issues and findings -it's easy to throw out the baby with the bath water. Abstract presented at the Cannabis Meeting, Canada, 1994.
35. Fried PA, O'Connell M (1987) A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Toxicol 9:79-85.
36. Frishknecht HR, Sieber B, Waser PG (1982) Effects of multiple, chronic and early hashish exposure on mating behavior, nest building and gestation in mice. Comp Biochem Physiol 72C:363-368.
37. Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 89:1646.
38. Hanuš L, Gopher A, Almog S, Mechoulam R (1993) Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J Med Chem 36:3032-3034.
39. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de-Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
40. Hingson R, Alpert JJ, Day N, Dooling E, Kayne H, Morelock S, Oppenheimer E, Zuckerman B (1982a) Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 70:539-546.
41. Hingson R, Gould JB, Morelock S, Kayne H, Heeren T, Alpert JJ, Zuckerman B, Day N (1982b) Maternal cigarette smoking, psychoactive substance use and infant Apgar scores. Am J Obstet Gynecol 144:959-966.
42. Hollister LE (1986) Health aspects of cannabis. Pharmacol Rev 38:1-20.
43. Hutchings DE, Brake SC, Morgan B (1989) Animal studies of prenatal delta-9-tetrahydrocannabinol: female embryolethality and effects on somatic and brain growth. Ann NY Acad Sci 562:133-144.
44. Hutchings DE, Fico TA, Banks AN, Dick LS, Brake SC (1991) Prenatal delta-9-tetrahydrocannabinol in the rat: effects on postweaning growth. Neurotoxicol Teratol 13:245-248.
45. Hutchings DE, Morgan B, Brake SC, Shi T, Lasalle E (1987) Delta-9-tetrahydrocannabinol during pregnancy in the rat: I. Differential effects on maternal nutrition, embryotoxicity, and growth in the offspring. Neurotoxicol Teratol 9:39-43.
46. Kent S, Bluthe R-M, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Pharmacol Sci 13:24-28.
47. Kluger MJ (1991) Fever: role of pyrogens and cryogens. Physiol Rev 34:687-695.
48. Kozak W, Conn CA, Kluger MJ (1994) Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am J Physiol 266 (2):R125-R135.
49. Mackie K, Devane WA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
50. Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38:45-74.
51. Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, et al. (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol Biochem Behav 40:471-478.
52. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
53. McLaughlin CR, Abood ME (1993) Developmental expression of cannabinoid receptor mRNA. Dev Brain Res 76:75-78.
54. Mechoulam R (1986) The pharmacohistory of Cannabis sativa. In: Mechoulam R (Ed) Cannabinoids as Therapeutic Agents. CRC, Boca Raton, pp 1-19.
55. Mechoulam R, Fride E (1995) The unpaved road to the endogenous cannabinoid ligand anandamide. In: Pertwee RG (Ed) Cannabinoids. Academic Press, London, pp 233-264.
56. Mechoulam R, Vogel Z, Barg J (1994) CNS cannabinoid receptors: role and therapeutic implications for CNS disorders. CNS Drugs 2:255-260.
57. Mirmiran M, Swaab DF (1987) Influence of drugs on brain neurotransmitter and behavioral states during development. Dev Pharmacol Ther 10:377-384.
58. Morgan B, Brake SC, Hutchings DE, Miller N, Gamagaris Z (1988) Delta-9-tetrahydrocannabinol during pregnancy in the rat: effects on development of RNA, DNA, and protein in offspring brain. Pharmacol Biochem Behav 31:365-369.
59. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
60. Murphy LL, Gher J, Szary A (1994) Prenatal cannabinoid exposure and effects on reproductive and immune parameters of the male and female offspring. Abstract presented at the International Cannabis Research Society, Canada, 1994.
61. Nahas G, Latour C (1992) The human toxicity of marijuana. Med J Aust 156:495-497.
62. Navarro M, Rodriguez-de-Fonseca F, Hernandez ML, Ramos JA, Fernandez-Ruiz JJ (1994) Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol Biochem Behav 47:47-58.
63. Navarro M, Rubio P (1994) Sex-dimorphic psychomotor activation after perinatal exposure to (-)-delta(9)-tetrahydrocannabinol. An ontogenetic study in Wistar rats. Psychopharmacol Berl 116:414-422.
64. Novogrodsky A, Vanichkin A, Parya M, Gazit A, Osherov N, Levitzki A (1994) Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
65. Opas EE, Bonney RJ, Humes JL (1985) Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J Invest Dermatol 84:253-256.
66. Pertwee RG (1972) Ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice. Br J Pharmacol 46:753-763.
67. Rodriguez de Fonseca F, Cebeira M, Fernandez-Ruiz JJ, Navarro M, Ramos JA (1991) Effects of preand perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43:713-723.
68. Rodriguez de Fonseca F, Ramos JA, Bonnin A, Fernandez-Ruiz JJ (1993) Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4:135-138.
69. Sciulli PW, Doyle WJ, Kelly C, Siegel P, Siegel MI (1979) The interaction of stressors in the induction of increased levels of fluctuating asymmetry in the laboratory rat. Am J Phys Anthropoly 50:279-284.
70. 9-tetrahydrocannabinol in the laboratory rat. Toxicol Appl Pharmacol 42:339-344.
71. Spear LP, Kirstein CL, Frambes NA (1989) Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies. Ann NY Acad Sci 562:290-307.
72. Stitt JT (1992) Prostaglandin, the OVLT and fever. In: Bartfai T, Ottoson D (Eds) Neuroimmunology of Fever, 1st edn. Pergamon Press, Oxford, pp 155-165.
73. Strijbos PJM, Horan MA, Carey F, Rothwell NJ (1993) Impaired febrile responses of aging mice are mediated by endogenous lipocortin-1 (annexin-1). Am J Physiol 265 (2:1):E289-E297.
74. Vardaris RM, Weisz DJ, Fazel A, Rawitch AB (1976) Chronic administration of delta-9-tetrahydrocannabinol to pregnant rats: studies of pup behavior and placental transfer. Pharmacol Biochem Behav 4:249-254.
75. Walters DE, Carr LA (1988) Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol Biochem Behav 29:213-216.
76. Ward IL (1972) Perinatal stress feminizes andm demasculinizes the behaviour of males. Science 175:82-84.
77. Wenger T, Croix D, Tramu G, Leonardelli J (1991) Prenatally administered delta-9-tetrahydrocannabinol temporarily inhibits the developing hypothalamo-pituitary system in rats. Pharmacol Biochem Behav 40:599-602.
78. Yirmiya R, Rosen H, Donchin O, Ovadia H (1994) Behavioral effects of lipopolysaccharide in rats: involvement of endogenous opioids. Brain Res 684:80-86.
79. Young JM, Spires DA, Spires MS, Bedord CJ, Wagner B, Ballaron S, De Young LM (1984) The mouse ear inflammatory response to topical arachidonic acid. J Invest Dermatol 82:367-371.
80. Zuckerman B, Frank D, Hingson R, Amaro H, Levenson SM, Kayne H, et al. (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320:762-768.